Avista Capital Partners is a private equity firm based in New York, specializing in investments in growth-oriented sectors such as energy, healthcare, communications, and media, as well as select industrial and consumer businesses. Founded in 2005, the firm targets mid-sized companies, typically investing between $50 million and $300 million in enterprises valued between $300 million and $2 billion. Avista focuses on sectors where its team has significant expertise, particularly in pharmaceuticals, medical devices, healthcare services, and data infrastructure. The firm employs a proactive approach to enhance value in its portfolio companies through active oversight and strategic guidance from a team of experienced professionals and industry executives. Avista seeks to establish controlling or influential minority stakes and primarily invests in U.S.-based companies while also considering opportunities in developed markets in Europe, South America, and Central America. With over $6 billion invested across more than 30 healthcare businesses, Avista aims to partner with strong management teams to drive growth and create sustainable value.
SolmeteX, Inc. manufactures amalgam separators for the dental industry in the United States and Canada. It offers collection containers; disposal kits for various sizes and types of dental practices; UN/DOT approved storage and shipping container; DOT/EPA approved storage/shipping containers; and Hg5 Plus system, a specialized solution that helps in reducing amalgam waste and dissolved mercury. The company sells its products through its dealer network in North America. SolmeteX, Inc. was founded in 1994 and is based in Northborough, Massachusetts.
SolmeteX, Inc. manufactures amalgam separators for the dental industry in the United States and Canada. It offers collection containers; disposal kits for various sizes and types of dental practices; UN/DOT approved storage and shipping container; DOT/EPA approved storage/shipping containers; and Hg5 Plus system, a specialized solution that helps in reducing amalgam waste and dissolved mercury. The company sells its products through its dealer network in North America. SolmeteX, Inc. was founded in 1994 and is based in Northborough, Massachusetts.
Vision Healthcare N.V. is a consumer healthcare company based in Kortrijk, Belgium, that specializes in the retail of self-care and over-the-counter (OTC) products. The company offers a diverse portfolio that includes cosmetics, vitamins, nutritional supplements, and personal care items. It employs an omnichannel marketing strategy to reach consumers, utilizing e-commerce, social media, influencers, mail order, home parties, and teleshopping. Vision Healthcare operates across several European countries, including the Netherlands, the United Kingdom, Belgium, and Germany. It is actively pursuing a buy-and-build strategy, consolidating various brands under a shared platform to facilitate sustainable growth and expansion within the European market.
GCM Global is a manufacturer based in Union City, California, specializing in high-precision components and assemblies for the industrial sector. With nearly 40 years of experience, the company offers a comprehensive array of services, including engineering, component manufacturing, supply chain management, precision machining, sheet metal fabrication, and precision assembly. GCM Global is dedicated to providing original equipment manufacturers (OEM) with reliable products, ensuring timely delivery and a wide range of design and manufacturing capabilities. The organization adheres to core values that emphasize professionalism and a commitment to creating exceptional customer experiences.
Braeburn Inc. is a pharmaceutical company focused on developing and commercializing treatments for serious central nervous system disorders, particularly opioid addiction. Founded in 2012 and based in Plymouth Meeting, Pennsylvania, Braeburn aims to address the significant challenges posed by opioid use disorder, a chronic condition that leads to structural and functional changes in the brain. The company's lead product is BRIXADI, an extended-release injectable formulation of buprenorphine designed for the treatment of moderate to severe opioid use disorder. Braeburn is dedicated to advancing next-generation therapies that offer individualized dosing regimens and various delivery options, thereby providing effective solutions for patients, healthcare providers, and society at large.
United BioSource Corporation is a healthcare company that specializes in providing a range of pharmaceutical support services to clients in the pharmaceutical and biotechnology sectors. The company offers comprehensive clinical development solutions, including management of registrational trials, long-term safety programs, and risk-based monitoring, as well as patient and physician recruitment. Additionally, United BioSource provides late-stage research services, market access programs, and real-world data analytics. The firm also delivers nursing services, reimbursement solutions, and patient assistance programs to facilitate healthcare access. Furthermore, the company supports product access and channel management through integrated pharmacy solutions and specialty pharmaceutical distribution services. Founded in 2003 and headquartered in Blue Bell, Pennsylvania, United BioSource Corporation operates as a subsidiary of Express Scripts Holding Company.
Miraca Life Sciences provides the highest quality anatomic pathology services, primarily in the fields of gastroenterology, dermatology, hematology, breast health, and urology. The company's team of more than 90 distinguished expert subspecialists utilizes state-of-the-art pathology laboratories to serve more than 5,500 patients every day. Miraca Life Sciences continuously improves diagnostic accuracy through consensus-based terminology and criteria, rigorous quality assurance, daily consensus conferences, extensive educational and training activities and close relationships with clinical partners.
National Spine & Pain Centers provides administrative services to interventional pain management clinics focused on relieving chronic back and neck pain. Interventional pain management is a rapidly growing medical specialty whose objective is to relieve pain through advanced, minimally invasive procedures while preventing costly, invasive surgery. Such treatment provides both immediate and long-lasting pain relief and enables patients and payors to avoid more costly and invasive surgical procedures from which recovery time can be lengthy. NSPC provides management services to physicians who are dedicated to providing high-quality patient care in outpatient ambulatory surgical center settings. Affiliated physicians are fellowship-trained and board-certified/board-eligible pain specialists and many are nationally recognized leaders in pain management. In 2011, the company was established in Rockville, Maryland.
OptiNose develops nasal drug delivery technologies and novel combination drug/device therapies. The drug delivery technologies are based upon a unique and patent-protected principal "Bi-Directional Delivery" which allows drugs to be more efficiently delivered to the nasal cavity. By applying its drug delivery technology, most of the dose is deposited beyond the nasal valve in the upper posterior two-thirds of the nasal cavity, unlike traditional devices. The OptiNose delivery devices have high dose reproducibility and avoid drug deposition to the lungs. In summary, technology fulfills the ideal requirements for nasal drug delivery. Clinical trials have shown that devices can provide a faster onset of action, greater effect with a lower dose, and reduced side effects. The company has offices in Norway and the UK.
OptiNose develops nasal drug delivery technologies and novel combination drug/device therapies. The drug delivery technologies are based upon a unique and patent-protected principal "Bi-Directional Delivery" which allows drugs to be more efficiently delivered to the nasal cavity. By applying its drug delivery technology, most of the dose is deposited beyond the nasal valve in the upper posterior two-thirds of the nasal cavity, unlike traditional devices. The OptiNose delivery devices have high dose reproducibility and avoid drug deposition to the lungs. In summary, technology fulfills the ideal requirements for nasal drug delivery. Clinical trials have shown that devices can provide a faster onset of action, greater effect with a lower dose, and reduced side effects. The company has offices in Norway and the UK.
OptiNose develops nasal drug delivery technologies and novel combination drug/device therapies. The drug delivery technologies are based upon a unique and patent-protected principal "Bi-Directional Delivery" which allows drugs to be more efficiently delivered to the nasal cavity. By applying its drug delivery technology, most of the dose is deposited beyond the nasal valve in the upper posterior two-thirds of the nasal cavity, unlike traditional devices. The OptiNose delivery devices have high dose reproducibility and avoid drug deposition to the lungs. In summary, technology fulfills the ideal requirements for nasal drug delivery. Clinical trials have shown that devices can provide a faster onset of action, greater effect with a lower dose, and reduced side effects. The company has offices in Norway and the UK.
Laredo Energy, LLC is a privately held company focused on the acquisition, exploration, and development of natural gas and oil reserves primarily in South Texas and East Central Texas. Established in 2001 and headquartered in Houston, Texas, the company operates a field office in Laredo. Laredo Energy has drilled over 200 operated wells in Webb and Zapata counties, with plans to drill 20 to 30 additional wells annually. The company exports and sells natural gas to various domestic and international markets. It is supported by equity investments from Avista Capital Partners and Liberty Energy Holdings, which is managed by Old Ironsides Energy.
Rottapharm’s long history of success began in 1961 with the creation of a small laboratory of independent research. From then on, the company has always invested on research, innovation, development and distribution on a world scale of new products mainly in the field of pharmaceutics and, in the following years, also in the fields of parapharmaceutics and nutraceutics. After acquiring the German multinational Madaus Pharma, the Group is currently one the most important pharmaceutical companies in Italy and is also present in over 85 countries worldwide.
Anthony, based in Sylmar, California, is a manufacturer and solutions provider specializing in glass refrigerator and freezer doors, along with associated products such as lighting systems and display equipment for commercial refrigeration systems. The company focuses on enhancing merchandising, ensuring food safety, and protecting the environment through its innovative designs. With over 50 years of experience, Anthony has established itself as a preferred supplier in the refrigeration industry by committing to quality, customer service, and continuous improvement. Their diverse product offerings also include beer cave doors, shelving, viewing windows, sliding doors, and various accessories, catering to a global market. Anthony is part of the Refrigeration and Food Equipment segment of Dover Corporation.
DataBank Holdings, Ltd. operates as a data center and co-location company based in Dallas, Texas, with additional facilities in Minneapolis/St. Paul, Kansas City, and Atlanta. Founded in 2004, DataBank provides a range of co-location solutions, including security, power configurations, and cooling. The company also offers managed services such as cloud computing, virtual hosting, network connectivity, and security, along with consulting services that cover design, implementation, migration, and compliance with various industry standards. Its clients span diverse sectors, including healthcare, finance, gaming, and hospitality, benefiting from DataBank's ability to help organizations manage risk and enhance their technology performance. The company’s infrastructure supports uninterrupted access to customer data and applications, enabling businesses to focus on their core objectives while ensuring data security and compliance.
OptiNose develops nasal drug delivery technologies and novel combination drug/device therapies. The drug delivery technologies are based upon a unique and patent-protected principal "Bi-Directional Delivery" which allows drugs to be more efficiently delivered to the nasal cavity. By applying its drug delivery technology, most of the dose is deposited beyond the nasal valve in the upper posterior two-thirds of the nasal cavity, unlike traditional devices. The OptiNose delivery devices have high dose reproducibility and avoid drug deposition to the lungs. In summary, technology fulfills the ideal requirements for nasal drug delivery. Clinical trials have shown that devices can provide a faster onset of action, greater effect with a lower dose, and reduced side effects. The company has offices in Norway and the UK.
WideOpenWest Networks, LLC provides broadband services to residential, business, and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Maryland, and the Southeast. The company offers a portfolio of services, including high-speed Internet, data, voice, cloud, and cable television services. It also provides business Internet, Ethernet, and optical networking services; business voice, hosted voice, voice trunking, and traditional PBX services; IaaS and hosting, backup and recovery, data center and colocation, and cloud backup services; and digital music services to small, medium, large/enterprise, and wholesale businesses operating in education, financial services, government, healthcare, hospitality, professional services, restaurants and bars, retail, and telecom services industries. The company was founded in 1996 and is based in Englewood, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.